Media formats available:
Recommended
- SGLT2 Inhibition, Diabetes and CVD: Where does this fit in CV risk management?HF & Diabetes: SGLT2 inhibition a paradigm shift?
John McMurray, MD
- SGLT2 Inhibition, Diabetes and CVD: Where does this fit in CV risk management?Challenging cardiovascular risk in diabetes: ready for a new approach?
John Deanfield, MD